Insider Trading & Ownership - 5AM Partners IV LLC

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for 5AM Partners IV LLC
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-04-10
Sale
2023-04-12
4:51 pm
Pear Therapeutics Inc. PEAR 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
16,544,113 $0.12 $1,985,294 200,000
(Indirect)
View
2022-11-11
Sale
2022-11-15
8:32 pm
Pear Therapeutics Inc. PEAR 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
105,281 $2.7381 $288,267 3,907,624
(Indirect)
View
2022-10-31
Sale
2022-11-02
7:49 pm
Pear Therapeutics Inc. PEAR 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
54,209 $2.7688 $150,096 3,911,835
(Indirect)
View
2022-10-06
Sale
2022-10-11
7:10 pm
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Ventures IV L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
600,000 $4.1482 $2,488,907 410,268
(Indirect)
View
2022-09-14
Sale
2022-09-16
6:03 pm
Pear Therapeutics Inc. PEAR 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
558,168 $1.8764 $1,047,322 3,914,004
(Indirect)
View
2022-09-06
Sale
2022-09-08
8:01 pm
Pear Therapeutics Inc. PEAR 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
770,000 $2.0543 $1,581,835 3,936,331
(Indirect)
View
2022-09-06
Sale
2022-09-08
7:58 pm
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Ventures IV L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
226,622 $4.8405 $1,096,953 503,112
(Indirect)
View
2022-08-16
Sale
2022-08-18
8:05 pm
Pear Therapeutics Inc. PEAR 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
400,000 $1.6501 $660,060 3,967,131
(Indirect)
View
2022-04-11
Sale
2022-04-13
4:51 pm
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Ventures IV L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
270,000 $5 $1,350,000 537,301
(Indirect)
View
2020-12-22
Sale
2020-12-28
9:35 pm
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
500,000 $12.82 $6,410,000 181,435
(Indirect)
View
2020-12-14
Sale
2020-12-16
7:15 pm
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
500,000 $12.25 $6,125,915 201,435
(Indirect)
View
2020-11-11
Sale
2020-11-13
8:53 pm
IDEAYA Biosciences Inc. IDYA 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
ROCKLAGE SCOTT M
Former 10% holder
10% Owner
800,000 $13.66 $10,928,000 384,496
(Indirect)
View
2020-10-05
Sale
2020-10-07
9:30 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
ROCKLAGE SCOTT M
Former 10% holder
175,000 $25.3 $4,427,500 2,037,654
(Indirect)
View
2020-06-16
Sale
2020-06-18
7:22 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
140,000 $33.3 $4,662,000 313,497
(Indirect)
View
2020-06-11
Sale
2020-06-15
9:12 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
245,000 $28.75 $7,044,412 414,105
(Indirect)
View
2020-05-19
Sale
2020-05-21
9:31 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
255,000 $35.15 $8,963,250 423,905
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2021-12-13
4:26 pm
N/A
N/A
Pear Therapeutics Inc. PEAR 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
10% Owner
0 $0 18,631,771
(Indirect)
View